LDE225 Diphosphate Catalog No.:M9943-10 Bumbacea RS

Bumbacea RS

Gene expression studies performed on tibialis samples revealed that both GLPG0492 was slowing down muscle loss by negatively interfering with major signaling pathways controlling muscle mass homeostasis

Cathepsin K inhibitors increase distal femoral bone mineral density in rapidly growing rabbits

Smiles: CC(=O)C1=CC=C(OCCCOC2C=CC(=CC=2)OCC(O)=O)C(CCC)=C1O

Co-Delivery of Docetaxel and Berbamine by Chitosan/Sulfobutylether-β-Cyclodextrin Nanoparticles for Enhancing Bioavailability and Anticancer Activities

LDE225 Diphosphate Catalog No.:M9943-10 Bumbacea RSSonidegib, also known as, erismodegib, LDE225, NVP LDE225, is an orally bioavailable small molecule Smoothened (Smo) antagonist with potential antineoplastic activity. Erismodegib selectively binds to the Hedgehog (Hh) ligand cell surface receptor Smo, which may result in the suppression of the Hh signaling pathway and, so, the inhibition of tumor cells in which this pathway is abnormally activated. It was approved by the FDA for treating basal cell